These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26763627)

  • 1. Association Patterns in Open Data to Explore Ciprofloxacin Adverse Events.
    Yildirim P
    Appl Clin Inform; 2015; 6(4):728-47. PubMed ID: 26763627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
    Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM
    Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database.
    Gandhi PK; Gentry WM; Bottorff MB
    Semin Arthritis Rheum; 2013 Jun; 42(6):562-6. PubMed ID: 23352248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
    Knudsen JF; Sokol GH; Flowers CM
    J Clin Pharm Ther; 2008 Oct; 33(5):513-9. PubMed ID: 18834366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
    Gandhi PK; Gentry WM; Bottorff MB
    Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
    Khadem TM; van Manen RP; Brown J
    Pharmacotherapy; 2014 Dec; 34(12):1324-9. PubMed ID: 25421400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.
    Johann-Liang R; Wyeth J; Chen M; Cope JU
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
    Szarfman A; Machado SG; O'Neill RT
    Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for linezolid-related blindness: a review of spontaneous adverse event reports.
    Brown J; Aitken SL; van Manen RP
    Pharmacotherapy; 2011 Jun; 31(6):585-90. PubMed ID: 21923442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental investigation of masking in the US FDA adverse event reporting system database.
    Wang HW; Hochberg AM; Pearson RK; Hauben M
    Drug Saf; 2010 Dec; 33(12):1117-33. PubMed ID: 21077702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine and aseptic meningitis.
    Simms KM; Kortepeter C; Avigan M
    Neurology; 2012 Mar; 78(12):921-7. PubMed ID: 22357718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data.
    Sessler NE; Walker E; Chickballapur H; Kacholakalayil J; Coplan PM
    Postgrad Med; 2017 Jan; 129(1):62-68. PubMed ID: 27977317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
    de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC;
    PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
    Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
    Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
    Hauben M; Horn S; Reich L
    Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
    O'Connell KA; Wood JJ; Wise RP; Lozier JN; Braun MM
    JAMA; 2006 Jan; 295(3):293-8. PubMed ID: 16418464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.